Description
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Cas No. | 2446480-97-1 |
|---|---|
| Purity | ≥98% |
| Formula | C27H25F3N8O |
| Formula Wt. | 534.55 |
| IUPAC Name | 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine |
| Synonym | USP1-IN-1; KSQ4279 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Cadzow L, Brenneman J, Sullivan P, et al. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer. 2020 Oct 1;138(Supplement 2,S52).
Cadzow L, Tobin E, Sullivan P, et al. Abstract ND01: KSQ-4279: A first-in-class USP1 inhibitor for the treatment of cancers with homologous recombination deficiencies. Cancer Res. 2022;82(12_Supplement):ND01.
Loratadine metabolite; FIASMA, histamine H1 ant...
Lck, Src, SIK inhibitor.
Synthesis impurity
TGFbeta receptor inhibitor
Endogenous peptide involved in vascular contrac...
NSAID; COX-1/2 inhibitor.
Naturally produced ITC, sulfonyl analog of sulf...
Fungal metabolite produced by Penicillium speci...
Hormonal attractant for male Bactrocera flies.<...
Macrolide antibiotic; peptidyl transferase inhi...
Neuraminidase inhibitor.
Calcitonin-family peptide frgament, involved in...
BH3 mimetic; Bcl-2, Bxl-xl, Bcl-w inhibitor.
Nav1.7 and Nav1.8 N1+ channel blocker.
Peptide, cleavage product of proenkephalin; κO...
Mycotoxin produced by Fusarium; sphingosine acy...
Cationic antimicrobial peptide, alters bacteria...
Geldanamycin derivative; HSP90 inhibitor.
AMPK activator.
Calcium channel blocker.